The rapidly changing management of cardiac arrhythmias

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 4 I, 2000, Pages 1070-1073

  Hammill, Stephen C ^a   Hubmayr, Rolf D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; IBUTILIDE FUMARATE; LIDOCAINE; PROCAINAMIDE; WARFARIN;

ANTICOAGULANT THERAPY; CARDIOVERSION; CATHETER ABLATION; CLINICAL TRIAL; DRUG EFFICACY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; OPEN HEART SURGERY; PRIORITY JOURNAL; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0034015528     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.4.16148     Document Type: Review

References (30)

1. Blackshear, J. L., S. L. Kopecky, S. C. Litin, R. E. Safford, and S. C. Hammill. 1996. Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment. Mayo Clin. Proc. 71:150-160.
2. SPAF Investigators. 1992. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann. Int. Med. 116:6-12.
3. Ezekowitz, M. D. 1999. Preventing stroke in patients with atrial fibrillation. J.A.M.A. 281:1830-1835.
4. Irani, W. N., P. A. Grayburn, and I. Afridi. 1997. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter: a prospective study using transesophageal echocardiography. Circulation 95:962-966.
5. Oral, H., J. J. Souza, G. F. Michaud, B. P. Knight, R. Goyal, S. A. Strickberger, and F. Morady. 1999. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N. Engl. J. Med. 340: 1849-1854.
6. The Planning and Steering Committees of the AFFIRM Study for the NHLBI AFFIRM Investigators. 1997. Atrial fibrillation follow-up investigation of rhythm management: The AFFIRM Study Design. Am. J. Cardiol. 79:1198-1202.
7. Morris, J. J., M. S. Stanton, and S. C. Hammill. 1995. The Maze procedure: a reproducibly safe and effective cure for refractory nonvalvular atrial fibrillation. Circulation 91:1-151.
8. Haissaguerre, M., P. Jais, D. C. Shah, A. Takihashi, M. Hocini, G. Quiniore, S. Garrigue, A. LeMouroux, P. LeMetayer, and J. Clementy. 1998. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339:659-666.
9. Farshi, R., D. Kistner, J. S. Sarma, J. A. Longmate, and B. N. Singh. 1999. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J. Am. Coll. Card. 33:304-310.
10. Marshall, H. J., Z. I. Harris, M. J. Griffith, R. L. Holder, and M. D. Gammage. 1999. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation. Circulation 99: 1587-1592.
11. Ommen, S. R., J. A. Odell, and M. S. Stanton. 1997. Atrial arrhythmias after cardiothoracic surgery. N. Engl. J. Med. 336:1429-1434.
12. Vanderlught, J. T., J. Mattioni, J. Denker, D. Torchiana, T. Ahern, L. K. Wakefield, K. T. Perry, and P. R. Kowey. 1999. Efficacy and safety of intravenous ibutilide for the conversion of atrial fibrillation after cardiac surgery. Circulation 100:369-375.
13. Kowey, P. R., J. E. Taylor, S. J. Rials, and R. A. Marinchak. 1992. Metaanalysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am. J. Cardiol. 69:963-964.
14. Daoud, E. G., S. A. Strickberger, K. C. Man, R. Goyal, G. M. Deeb, S. F. Boiling, F. D. Pagani, C. Bitar, M. D. Meissner, and F. Morady. 1997. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N. Engl. J. Med. 337:1785-1791.
15. Guarnieri, T., S. Nolan, S. O. Gottlieb, A. Dudek, and D. R. Lowry. 1999. Intravenous amiodarone for the prevention of atrial fibrillation after open-heart surgery: the amidodarone reduction in coronary heart (ARCH) trial. J. Am. Coll. Cardiol. 34:343-347.
16. Daoud, E. G., and F. Morady. 1998. Pathophysiology of atrial flutter. Ann. Rev. Med. 49:77-83.
17. Volgman, A. S., P. A. Carberry, B. Stambler, W. R. Lewis, G. H. Dunn, K. T. Perry, J. T. Vanderlugt, and P. R. Kowey. 1998. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J. Am. Coll. Cardiol. 31:1414-1419.
18. Paydak, H., J. G. Kall, M. C. Burke, D. Rubenstein, D. E. Kopp, R. J. Verdino, and D. J. Wilber. 1998. Atrial fibrillation after radiofrequency ablation of Type I atrial flutter. Circulation 98:315-322.
19. Morady, F. 1999. Radiofrquency ablation as treatment for cardiac arrhythmias. N. Engl. J. Med. 340:534-544.
20. Cannom, D. S., and E. P. Prystowsky. 1999. Management of ventricular arrhythmias. J.A.M.A. 281:172-179.
21. Moss, A. J., H. J. Hall, D. S. Cannom, J. P. Daubert, S. L. Higgins, H. Klein, J. H. Levine, S. Saksena, A. L. Waldo, D. Wilber, M. W. Brown, and M. Heo. 1996. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med. 335:1933-1940.
22. Buxton, A. E. 1999. Presentation for the MUSTT investigators of the Multicenter Unsustained Tachycardia Trial. American College of Cardiology Annual Scientific Session, New Orleans, LA.
23. Hammill, S. C., and D. L. Packer. 1996. Amiodarone in congestive heart failure: unraveling the GESICA and CHF-STAT differences. Brit. Heart J. 75:1:6-7.
24. The Investigators of the Antiarrhythmics versus Implantable Defibrillators (AVID) Trial. 1997. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med. 337:1576-1583.
25. Tchou, P., and A. A. Mehdirad. 1995. Bundle branch reentry ventricular tachycardia. P.A.C.E. 18:1427-1437.
26. Rodriquez, L. M., J. L. Smeets, C. Timmermans, and H. J. Wellens. 1997. Predictors of successful ablation of right and left-sided idiopathic ventricular tachycardia. Am. J. Cardiol. 79:309-314.
27. Varma, N., and M. E. Josephson. 1997. Therapy of "idiopathic" ventricular tachycardia. J. Cardiovasc. Electrophys. 8:104-116.
28. Ackerman, M. J. 1998. The long QT syndrome: ion channel diseases of the heart. Mayo Clin. Prof. 73:250-269.
29. Gregoratos, G., M. D. Cheitlin, A. Conill, A. E. Epstein, C. Fellows, T. B. Ferguson, R. A. Freedman, M. A. Hlacky, G. V. Naccarelli, S. Saksena, R. S. Schlant, and M. J. Silka. 1998. Executive summary: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Circulation 97:1325-1335.
30. Gorgels, A. P., A. van den Dool, A. Hofs, A. Mulleneers, J. L. Smeets, M. A. Vos, and H. J. Wellens. 1996. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am. J. Cardiol. 78:43-46.